Sidhaant Life Sciences Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sidhaant Life Sciences Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $3.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sidhaant Life Sciences Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $3.0M Trade | TransData Nexus

Who is Sidhaant Life Sciences Private Limited? — Company Overview & Market Position

Sidhaant Life Sciences Private Limited, incorporated on October 1, 2004, is a private limited company based in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U51397DL2004PTC129632. Its authorized capital stands at ₹10 million, with a paid-up capital of ₹7.65 million. The registered office is located at 808 8th Floor, Vishal Tower, District Centre, Janakpuri, New Delhi, 110058.

Sidhaant Life Sciences specializes in the wholesale and retail trade of pharmaceutical products, including tablets, capsules, syrups, and injections. The company has a workforce of approximately 12 employees as of April 8, 2024. Financially, the company reported a 24.8% decrease in total revenue for the fiscal year 2023, with a net profit decline of 69.49%.

What Does Sidhaant Life Sciences Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Folic$1.0M 2Quinine$850.0K 3Erythromycin$750.0K 4Enoxaparin$400.0K

Sidhaant Life Sciences Private Limited Therapeutic Categories — 4 Specializations

Sidhaant Life Sciences Private Limited operates across 4 therapeutic categories, with Nutritional Supplements (34.3%), Antimalarial & Antiparasitic (27.9%), Antibiotics (24.6%) representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Nutritional Supplements

1 products · 34.3% · $1.0M

Antimalarial & Antiparasitic

1 products · 27.9% · $850.0K

Antibiotics

1 products · 24.6% · $750.0K

Cardiovascular

1 products · 13.1% · $400.0K

Product Portfolio — Top 4 by Export Value

Sidhaant Life Sciences Private Limited exports 4 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Folic	Nutritional Supplements	$1.0M	23	1.9%

Key Metrics

Total Trade$3.0M

Products4

Shipments63

Categories4

#1 Rankings0

Top 5 Concentration100.0%

Top Categories

Nutritional Supplements34.3%

Antimalarial & Antiparasitic27.9%

Antibiotics24.6%

Last updated: March 28, 2026

Sidhaant Life Sciences Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sidhaant Life Sciences operates manufacturing facilities in New Delhi and Gurugram, Haryana. The New Delhi facility is situated at 808 8th Floor, Vishal Tower, District Centre, Janakuri, New Delhi, 110058. The Gurugram facility is located at Basement, Ground, and First Floor, Plot-459, Phase III, Udyog Vihar, Gurugram, Haryana, 122008. Specific details regarding production capacities and specializations are not publicly disclosed.

Buyer Due Diligence Brief — Evaluating Sidhaant Life Sciences Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sidhaant Life Sciences has a track record of consistent export activities, with a total export value of $3.0 million USD across 63 shipments from 2022 to 2026. The company's portfolio includes four products across four therapeutic categories, with the top five products contributing to 100% of the export value. This indicates a focused approach to its export strategy, emphasizing quality and specialization.

2Certifications to Verify

Importers should verify the following certifications when considering products from Sidhaant Life Sciences:

FDA Approval: Confirm the FDA registration status of the manufacturing facility and the approval of specific products.

WHO-GMP Certification: Ensure the manufacturing facility holds valid WHO-GMP certification, indicating compliance with international quality standards.

EU GMP Certification: Verify the validity of EU GMP certification for the manufacturing facility, ensuring adherence to European Union quality standards.

ISO Certification: Check for ISO certifications related to quality management systems, such as ISO 9001, to assess the company's commitment to quality.

To verify these certifications, importers can request copies of the certificates from Sidhaant Life Sciences and cross-reference them with the issuing authorities' official records.

3Due Diligence Checklist

When conducting due diligence on Sidhaant Life Sciences, importers should consider the following steps:

Verify Regulatory Approvals: Confirm the validity of FDA, WHO-GMP, EU GMP, and ISO certifications.

Assess Financial Health: Review the company's financial statements for the past three years to evaluate profitability and financial stability.

Evaluate Product Quality: Request product samples and conduct quality assessments to ensure compliance with international standards.

Check Export History: Review the company's export records to assess consistency and reliability in fulfilling international orders.

Inspect Manufacturing Facilities: If possible, conduct site visits to the manufacturing facilities to assess compliance with quality standards and regulatory requirements.

Red flags to watch for include discrepancies in certification documents, irregularities in financial records, and a lack of transparency in manufacturing processes. Recommended pre-order checks involve verifying the authenticity of certifications, assessing the company's reputation in the industry, and ensuring clear communication regarding product specifications and delivery timelines.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Supplier Matching: Sidhaant Life Sciences Private Limited identified across shipments using name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
3.Market Share: Calculated per product as Sidhaant Life Sciences Private Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 63 individual customs records matching Sidhaant Life Sciences Private Limited.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Products Tracked

4 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Sidhaant Life Sciences Private Limited

Sidhaant Life Sciences Private Limited — Export Portfolio & Destination Treemap

Who is Sidhaant Life Sciences Private Limited? — Company Overview & Market Position

What Does Sidhaant Life Sciences Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Sidhaant Life Sciences Private Limited Therapeutic Categories — 4 Specializations

Product Portfolio — Top 4 by Export Value

Key Metrics

Top Categories

Sidhaant Life Sciences Private Limited — Corporate Profile & Information

1Corporate Overview

2Manufacturing Facilities

Top Export Routes

Related Analysis

Need Detailed Data?

3Key Leadership

Where Does Sidhaant Life Sciences Private Limited Export? — Destination Intelligence

1Regulated Markets

2Emerging Markets

3Geographic Strategy

Sidhaant Life Sciences Private Limited — Manufacturing & Regulatory Profile

1FDA Status

2WHO & EU GMP

3CDSCO & Indian Regulatory

4Recent Regulatory Actions

Sidhaant Life Sciences Private Limited — Competitive Positioning Among Indian Pharma Exporters

1Competitive Landscape

2Key Differentiators

3Strategic Position

Buyer Due Diligence Brief — Evaluating Sidhaant Life Sciences Private Limited as a Supplier

1Supplier Assessment

2Certifications to Verify

3Due Diligence Checklist

Frequently Asked Questions — Sidhaant Life Sciences Private Limited

How many pharmaceutical products does Sidhaant Life Sciences Private Limited export from India?

What is Sidhaant Life Sciences Private Limited's total pharmaceutical export value?

What therapeutic categories does Sidhaant Life Sciences Private Limited cover?

Get Full Sidhaant Life Sciences Private Limited Export Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology